Biovica International AB (BIOVIC B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Biovica International AB (Biovica) is a biotech company that develops and commercializes blood-based biomarker assays to enhance the monitoring of modern cancer therapies and better predict patient outcome. The company develops DiviTum, a biomarker test that measures the activity of the enzyme thymidine kinase-1 in blood serum or cell cultures. It conducts clinical studies to generate clinical data on the performance of DiviTum with various conditions associated with unregulated cell growth and increased cell proliferation, including advanced breast cancer and other solid tumors and cell-cycle regulating drugs. It collaborates with cancer institutes and pharmaceutical companies to launch next-generation therapies, and promote the growing drive towards personalized medicine. Biovica is headquartered in Uppsala, Sweden.

Biovica International AB (BIOVIC B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Biovica International AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biovica International AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biovica International AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biovica International AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biovica International AB, Medical Devices Deals, 2012 to YTD 2018 9
Biovica International AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Biovica International AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Biovica Enters into Agreement with WntResearch 11
Biovica Enters into Research Agreement with Karolinska Institutet 12
Biovica Enters into Agreement with Pelago Bioscience 13
Biovica International AB - Key Competitors 14
Biovica International AB - Key Employees 15
Biovica International AB - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Corporate Communications 17
Feb 20, 2017: Biovica announces new appointments 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List Of Tables


Biovica International AB, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Biovica International AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biovica International AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biovica International AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biovica International AB, Deals By Therapy Area, 2012 to YTD 2018 8
Biovica International AB, Medical Devices Deals, 2012 to YTD 2018 9
Biovica International AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Biovica Enters into Agreement with WntResearch 11
Biovica Enters into Research Agreement with Karolinska Institutet 12
Biovica Enters into Agreement with Pelago Bioscience 13
Biovica International AB, Key Competitors 14
Biovica International AB, Key Employees 15
Biovica International AB, Subsidiaries 16

List Of Figures


Biovica International AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Biovica International AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Biovica International AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Biovica International AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Biovica International AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biovica International AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Biovica International AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biovica International AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biovica International AB, Medical Devices Deals, 2012 to YTD 2018 9

Biovica International AB (BIOVIC B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Biovica International AB (Biovica) is a biotech company that develops and commercializes blood-based biomarker assays to enhance the monitoring of modern cancer therapies and better predict patient outcome. The company

USD 250 View Report

Biovica International AB (BIOVIC B) - Medical Equipment - Deals and Alliances Profile

Biovica International AB (Biovica) is a biotech company that focuses on the development and commercialization of blood-based biomarker assays. The companys DiviTum is a biomarker test that has been developed

USD 250 View Report

West International AB Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

West International AB Company Profile is a detailed strategic and analytical report on West International AB. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

Novus Group International AB Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Novus Group International AB Company Profile is a detailed strategic and analytical report on Novus Group International AB. The 2018 version of the report offers detailed insights into the companys

USD 200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available